This overlooked FTSE 100 dividend and growth stock has been thrashing the index
The Motley Fool
Published Apr 25, 2019 15:24
Updated Apr 25, 2019 15:36
Information service provider Relx (LSE: REL) is one of those stocks that it is all too easy to overlook. It’s hardly a household name, but with a market cap of almost £35bn, it’s bigger than far better known companies such as Barclays (LON:BARC), National Grid (LON:NG), Tesco (LON:TSCO), BT Group (LON:BT) and Aviva (LON:AV). In fact, even I was surprised how big. Then again, I haven’t looked at the stock for two years.
Another good year This morning it published a trading update that confirmed its full-year outlook is unchanged, with key business trends broadly consistent with last year’s. This puts Relx on course to deliver “another year of underlying growth in revenue and in adjusted operating profit, together with growth in adjusted earnings per share on a constant currency basis”.
Relx, formerly known as Reed Elsevier (LON:REL), is a global provider of information-based analytics and decision tools for professional and business customers, operating in more than 180 countries with offices in 40. It employs more than 30,000 people, roughly half in North America. This gives it a global reach and respite from Brexit uncertainties.
Organic planet Today’s update said the group continues to focus on the organic development of increasingly sophisticated information-based analytics and decision tools, and is targeting selective acquisitions to support this. It has been active on this front, completing five acquisitions totalling £236m this year alone.
Management is also being generous with shareholders, having recently completed £250m of a £600m share buy-back, with the remaining £350m to be shared out by the end of the year.
Moving on from print Relx has risen to the challenge of developing information-based analytics tools to counter sliding revenues from its traditional print publishing business. Its share price is up 96% over five years, against growth of just 12% on the FTSE 100 over the same period.
Get The App
When I looked at the stock in September 2017, I was a little wary of its low yield, then 2.6%, and high valuation of 20.9 times forecast earnings, and suggested this one might be best to buy on the dips.
Dividend surge Today the yield is still 2.6%, covered twice, but as Kevin Godbold points out, the group’s impressive revenue, cash flow and earnings growth have driven an almost 70% increase in dividend payments over the past five years. This comes on top of that 96% share price growth.
Last month it suffered a blow when the University of California cancelled its subscriptions with the company’s Dutch-based Elsevier academic journals subsidiary, after it refused to make all articles published by its authors immediately free for readers worldwide.
Open access That contract was worth just $11m in 2018, a tiny proportion of the group’s total £7.49bn revenues, the worry is that other universities will follow suit. We have seen how the drive towards free information has hit newspapers, and Relx may not be immune.
The group now trades at 18 times forecast revenues, while City analysts expect bullish earnings per share growth of 26% this year, and 7% in 2020. I’d say this is either a buy, or one for your watchlist. GA Chester has no doubt. He would buy and hold it for decades .
us better investors.
Motley Fool UK 2019
First published on The Motley Fool
Written By: The Motley Fool
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.